HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method

Masakazu Nakamura, Shinji Yokoyama, Yuzo Kayamori, Hiroyasu Iso, Akihiko Kitamura, Tomonori Okamura, Masahiko Kiyama, Hiroyuki Noda, Kunihiro Nishimura, Michikazu Nakai, Isao Koyama, Mahnaz Dasti, Hubert W. Vesper, Tamio Teramoto, Yoshihiro Miyamoto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background: Accurate high-density lipoprotein cholesterol (HDL-C) measurements are important for management of cardiovascular diseases. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform ultracentrifugation (UC) reference measurement procedure (RMP) to value assign HDL-C. Japanese CRMLN laboratory (Osaka) concurrently runs UC procedure and the designated comparison method (DCM). Osaka performance of UC and DCM was examined and compared with CDC RMP. Methods: CDC RMP involved UC, heparin-MnCl2 precipitation, and cholesterol analysis. CRMLN DCM for samples containing <200mg/dl triglycerides involved 50-kDa dextran sulfate-MgCl2 precipitation and cholesterol determination. Results: HDL-C regression equations obtained with CDC (x) and Osaka (y) were y=0.992x+0.542 (R2=0.996) for Osaka UC and y=1.004x-0.181 (R2=0.998) for DCM. Pass rates within ±1mg/dl of the CDC target value were 91.9 and 92.1% for Osaka UC and DCM, respectively. Biases at 40mg/dl HDL-C were +0.22 and -0.02mg/dl for Osaka UC and DCM, respectively. Conclusions: Osaka UC and DCM were highly accurate, precise, and stable for many years, assisting manufacturers to calibrate products for clinical laboratories to accurately measure HDL-C for patients, calculate non-HDL-C, and estimate low-density lipoprotein cholesterol with the Friedewald equation.

Original languageEnglish
Pages (from-to)185-190
Number of pages6
JournalClinica Chimica Acta
Volume439
DOIs
Publication statusPublished - 2015 Jan 5

Fingerprint

Ultracentrifugation
HDL Cholesterol
Disease control
Cholesterol
Centers for Disease Control and Prevention (U.S.)
Clinical laboratories
Lipoproteins
Dextran Sulfate
Magnesium Chloride
LDL Cholesterol
Heparin
Triglycerides

Keywords

  • CDC
  • CRMLN
  • Designated comparison method
  • HDL cholesterol
  • Ultracentrifugation

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method. / Nakamura, Masakazu; Yokoyama, Shinji; Kayamori, Yuzo; Iso, Hiroyasu; Kitamura, Akihiko; Okamura, Tomonori; Kiyama, Masahiko; Noda, Hiroyuki; Nishimura, Kunihiro; Nakai, Michikazu; Koyama, Isao; Dasti, Mahnaz; Vesper, Hubert W.; Teramoto, Tamio; Miyamoto, Yoshihiro.

In: Clinica Chimica Acta, Vol. 439, 05.01.2015, p. 185-190.

Research output: Contribution to journalArticle

Nakamura, M, Yokoyama, S, Kayamori, Y, Iso, H, Kitamura, A, Okamura, T, Kiyama, M, Noda, H, Nishimura, K, Nakai, M, Koyama, I, Dasti, M, Vesper, HW, Teramoto, T & Miyamoto, Y 2015, 'HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method', Clinica Chimica Acta, vol. 439, pp. 185-190. https://doi.org/10.1016/j.cca.2014.10.039
Nakamura, Masakazu ; Yokoyama, Shinji ; Kayamori, Yuzo ; Iso, Hiroyasu ; Kitamura, Akihiko ; Okamura, Tomonori ; Kiyama, Masahiko ; Noda, Hiroyuki ; Nishimura, Kunihiro ; Nakai, Michikazu ; Koyama, Isao ; Dasti, Mahnaz ; Vesper, Hubert W. ; Teramoto, Tamio ; Miyamoto, Yoshihiro. / HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method. In: Clinica Chimica Acta. 2015 ; Vol. 439. pp. 185-190.
@article{e422a33edf7946ee9d05cde30e018782,
title = "HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method",
abstract = "Background: Accurate high-density lipoprotein cholesterol (HDL-C) measurements are important for management of cardiovascular diseases. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform ultracentrifugation (UC) reference measurement procedure (RMP) to value assign HDL-C. Japanese CRMLN laboratory (Osaka) concurrently runs UC procedure and the designated comparison method (DCM). Osaka performance of UC and DCM was examined and compared with CDC RMP. Methods: CDC RMP involved UC, heparin-MnCl2 precipitation, and cholesterol analysis. CRMLN DCM for samples containing <200mg/dl triglycerides involved 50-kDa dextran sulfate-MgCl2 precipitation and cholesterol determination. Results: HDL-C regression equations obtained with CDC (x) and Osaka (y) were y=0.992x+0.542 (R2=0.996) for Osaka UC and y=1.004x-0.181 (R2=0.998) for DCM. Pass rates within ±1mg/dl of the CDC target value were 91.9 and 92.1{\%} for Osaka UC and DCM, respectively. Biases at 40mg/dl HDL-C were +0.22 and -0.02mg/dl for Osaka UC and DCM, respectively. Conclusions: Osaka UC and DCM were highly accurate, precise, and stable for many years, assisting manufacturers to calibrate products for clinical laboratories to accurately measure HDL-C for patients, calculate non-HDL-C, and estimate low-density lipoprotein cholesterol with the Friedewald equation.",
keywords = "CDC, CRMLN, Designated comparison method, HDL cholesterol, Ultracentrifugation",
author = "Masakazu Nakamura and Shinji Yokoyama and Yuzo Kayamori and Hiroyasu Iso and Akihiko Kitamura and Tomonori Okamura and Masahiko Kiyama and Hiroyuki Noda and Kunihiro Nishimura and Michikazu Nakai and Isao Koyama and Mahnaz Dasti and Vesper, {Hubert W.} and Tamio Teramoto and Yoshihiro Miyamoto",
year = "2015",
month = "1",
day = "5",
doi = "10.1016/j.cca.2014.10.039",
language = "English",
volume = "439",
pages = "185--190",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - HDL cholesterol performance using an ultracentrifugation reference measurement procedure and the designated comparison method

AU - Nakamura, Masakazu

AU - Yokoyama, Shinji

AU - Kayamori, Yuzo

AU - Iso, Hiroyasu

AU - Kitamura, Akihiko

AU - Okamura, Tomonori

AU - Kiyama, Masahiko

AU - Noda, Hiroyuki

AU - Nishimura, Kunihiro

AU - Nakai, Michikazu

AU - Koyama, Isao

AU - Dasti, Mahnaz

AU - Vesper, Hubert W.

AU - Teramoto, Tamio

AU - Miyamoto, Yoshihiro

PY - 2015/1/5

Y1 - 2015/1/5

N2 - Background: Accurate high-density lipoprotein cholesterol (HDL-C) measurements are important for management of cardiovascular diseases. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform ultracentrifugation (UC) reference measurement procedure (RMP) to value assign HDL-C. Japanese CRMLN laboratory (Osaka) concurrently runs UC procedure and the designated comparison method (DCM). Osaka performance of UC and DCM was examined and compared with CDC RMP. Methods: CDC RMP involved UC, heparin-MnCl2 precipitation, and cholesterol analysis. CRMLN DCM for samples containing <200mg/dl triglycerides involved 50-kDa dextran sulfate-MgCl2 precipitation and cholesterol determination. Results: HDL-C regression equations obtained with CDC (x) and Osaka (y) were y=0.992x+0.542 (R2=0.996) for Osaka UC and y=1.004x-0.181 (R2=0.998) for DCM. Pass rates within ±1mg/dl of the CDC target value were 91.9 and 92.1% for Osaka UC and DCM, respectively. Biases at 40mg/dl HDL-C were +0.22 and -0.02mg/dl for Osaka UC and DCM, respectively. Conclusions: Osaka UC and DCM were highly accurate, precise, and stable for many years, assisting manufacturers to calibrate products for clinical laboratories to accurately measure HDL-C for patients, calculate non-HDL-C, and estimate low-density lipoprotein cholesterol with the Friedewald equation.

AB - Background: Accurate high-density lipoprotein cholesterol (HDL-C) measurements are important for management of cardiovascular diseases. The US Centers for Disease Control and Prevention (CDC) and Cholesterol Reference Method Laboratory Network (CRMLN) perform ultracentrifugation (UC) reference measurement procedure (RMP) to value assign HDL-C. Japanese CRMLN laboratory (Osaka) concurrently runs UC procedure and the designated comparison method (DCM). Osaka performance of UC and DCM was examined and compared with CDC RMP. Methods: CDC RMP involved UC, heparin-MnCl2 precipitation, and cholesterol analysis. CRMLN DCM for samples containing <200mg/dl triglycerides involved 50-kDa dextran sulfate-MgCl2 precipitation and cholesterol determination. Results: HDL-C regression equations obtained with CDC (x) and Osaka (y) were y=0.992x+0.542 (R2=0.996) for Osaka UC and y=1.004x-0.181 (R2=0.998) for DCM. Pass rates within ±1mg/dl of the CDC target value were 91.9 and 92.1% for Osaka UC and DCM, respectively. Biases at 40mg/dl HDL-C were +0.22 and -0.02mg/dl for Osaka UC and DCM, respectively. Conclusions: Osaka UC and DCM were highly accurate, precise, and stable for many years, assisting manufacturers to calibrate products for clinical laboratories to accurately measure HDL-C for patients, calculate non-HDL-C, and estimate low-density lipoprotein cholesterol with the Friedewald equation.

KW - CDC

KW - CRMLN

KW - Designated comparison method

KW - HDL cholesterol

KW - Ultracentrifugation

UR - http://www.scopus.com/inward/record.url?scp=84909952744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909952744&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2014.10.039

DO - 10.1016/j.cca.2014.10.039

M3 - Article

VL - 439

SP - 185

EP - 190

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -